Kura Oncology (KURA) Ownership - Who owns Kura Oncology?
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KURA showed earnings on August 07, 2025. You can read more about the earnings report here.